Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q4 FY25 results · Jan–Mar 2025
Abbott India reported revenue from operations of ₹1,604.59 crore (up 11.5% from Q4 FY24) and net profit of ₹367.04 crore (up 27.9% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,604.59 | 1,438.63 | +11.5% | 1,614.28 | −0.6% |
| Other income | 76.02 | 81.15 | −6.3% | 71.75 | +6.0% |
| Total income | 1,680.61 | 1,519.78 | +10.6% | 1,686.03 | −0.3% |
| Profit before tax | 482.71 | 389.68 | +23.9% | 487.59 | −1.0% |
| Net profit for the period | 367.04 | 287.06 | +27.9% | 360.78 | +1.7% |
| EPS, basic (₹) | 172.72 | 565.28 | −69.4% | 169.78 | +1.7% |
| Net margin (%) | 22.9 | 20.0 | 22.3 |
Standalone
- Filed with BSE
- 09 Jun 2025, 16:02 IST
- Board meeting
- 15 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE